Scholarly Index
Lynn McRoy
Pfizer (United States); 959 total citations; 73 total publications; best world rank #230
Pfizer (United States)
959Total citations
73Total publications
16H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Advanced Breast Cancer Therapies | 2021-2025 | 344 | US 127 | 93.81 |
| Cancer-related Molecular Pathways | 2021-2025 | 230 | US 95 | 89.28 |
| Breast Cancer Treatment Studies | 2021-2025 | 883 | US 304 | 90.95 |
| HER2/EGFR in Cancer Research | 2021-2025 | 930 | US 308 | 85.51 |